By Josh White
Date: Wednesday 10 Sep 2025
(Sharecast News) - Anpario reported a sharp rise in earnings for the first half of 2025 on Wednesday, driven by strong international sales and the contribution from its Bio-Vet acquisition in the United States.
Director/PDMR Shareholding | 10-Sep-2025 | 15:30 | RNS |
Interim Results | 10-Sep-2025 | 07:00 | RNS |
Chill appointed Distributor - ELF Nicotine Pouches | 10-Sep-2025 | 07:00 | RNS |
Transaction in Own Shares | 10-Sep-2025 | 07:00 | RNS |
Transaction in Own Shares | 10-Sep-2025 | 07:00 | RNS |
Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
Investment Column:BTG | 06-Oct-2011 | The Independent |
Investment Column:Genus | 09-Sep-2011 | The Independent |
Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
Price | 22,300.44 |
Closing Price Change | -51.33 |
% Change | -0.23 % |
09-Sep-25 Close | 22,300.44 |
You are here: research